Drug information for NICARDIPINE HYDROCHLORIDE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 20MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine BARR 74439
CAPSULE; ORAL 30MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine BARR   "
CAPSULE; ORAL 20MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine TEVA 74540
CAPSULE; ORAL 30MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine TEVA   "
CAPSULE; ORAL 20MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine MYLAN 74642
CAPSULE; ORAL 30MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine MYLAN   "
CAPSULE; ORAL 20MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine WATSON LABS 74670
CAPSULE; ORAL 30MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine WATSON LABS   "
CAPSULE; ORAL 20MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine EPIC PHARMA 74928
1998-03-19 Review
1998-03-19 Letter
1998-03-19 Label
CAPSULE; ORAL 30MG Prescription AB  NICARDIPINE HYDROCHLORIDE Nicardipine EPIC PHARMA   "
INJECTABLE; INJECTION 25MG/10ML (2.5MG/ML) Prescription AP  NICARDIPINE HYDROCHLORIDE Nicardipine EXELA PHARMA SCIENCE 22276
2009-01-14 Label
2009-01-12 Letter
2008-10-09 Review
2008-10-09 Summary Review
2008-07-31 Letter
2008-07-29 Label
INJECTABLE; INJECTION 25MG/10ML (2.5MG/ML) Prescription AP  NICARDIPINE HYDROCHLORIDE Nicardipine SUN PHARMA GLOBAL 78405
INJECTABLE; INJECTION 25MG/10ML (2.5MG/ML) Prescription AP  NICARDIPINE HYDROCHLORIDE Nicardipine BEDFORD 78714
INJECTABLE; INJECTION 25MG/10ML (2.5MG/ML) Prescription AP  NICARDIPINE HYDROCHLORIDE Nicardipine NAVINTA LLC 90125
INJECTABLE; INJECTION 25MG/10ML (2.5MG/ML) Prescription AP  NICARDIPINE HYDROCHLORIDE Nicardipine PHARMAFORCE 90534
INJECTABLE; INJECTION 25MG/10ML (2.5MG/ML) Prescription AP  NICARDIPINE HYDROCHLORIDE Nicardipine BIONICHE PHARMA USA 90664
INJECTABLE; INJECTION 25MG/10ML (2.5MG/ML) Prescription AP  NICARDIPINE HYDROCHLORIDE Nicardipine WOCKHARDT 90671

Drug Adverse Effects information for NICARDIPINE HYDROCHLORIDE

Role code Indications Reaction # Reports
PS BLOOD PRESSURE GLARE 2
PS BLOOD PRESSURE PHOTOPHOBIA 2
PS BLOOD PRESSURE VISION BLURRED 2
SS DEPRESSION CAESAREAN SECTION 2
SS DEPRESSION GESTATIONAL HYPERTENSION 2
SS DEPRESSION MATERNAL EXPOSURE DURING PREGNANCY 2
SS DEPRESSION PREGNANCY 1
SS DEPRESSION PREMATURE DELIVERY 2
SS HYPERTENSION CAESAREAN SECTION 4
SS HYPERTENSION CEREBRAL INFARCTION 4
SS HYPERTENSION GESTATIONAL HYPERTENSION 4
SS HYPERTENSION MATERNAL EXPOSURE DURING PREGNANCY 4
SS HYPERTENSION PREGNANCY 2
SS HYPERTENSION PREMATURE DELIVERY 4
SS HYPERURICAEMIA CEREBRAL INFARCTION 2
SS HYPOTHYROIDISM CAESAREAN SECTION 2
SS HYPOTHYROIDISM GESTATIONAL HYPERTENSION 2
SS HYPOTHYROIDISM MATERNAL EXPOSURE DURING PREGNANCY 2
SS HYPOTHYROIDISM PREGNANCY 1
SS HYPOTHYROIDISM PREMATURE DELIVERY 2
SS MATERNAL EXPOSURE DURING PREGNANCY CAESAREAN SECTION 4
SS MATERNAL EXPOSURE DURING PREGNANCY FOETAL GROWTH RESTRICTION 4
SS MATERNAL EXPOSURE DURING PREGNANCY FOETAL HEART RATE ABNORMAL 4
SS MATERNAL EXPOSURE DURING PREGNANCY JAUNDICE NEONATAL 4
SS MATERNAL EXPOSURE DURING PREGNANCY MATERNAL DRUGS AFFECTING FOETUS 4
SS MATERNAL EXPOSURE DURING PREGNANCY PREMATURE BABY 4
SS MATERNAL EXPOSURE DURING PREGNANCY RECTAL HAEMORRHAGE 4
C ACUTE MYELOID LEUKAEMIA ACUTE GRAFT VERSUS HOST DISEASE 30
C ACUTE MYELOID LEUKAEMIA CHRONIC GRAFT VERSUS HOST DISEASE 30
C ACUTE MYELOID LEUKAEMIA CYTOMEGALOVIRUS VIRAEMIA 30
C ACUTE MYELOID LEUKAEMIA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 30
C ACUTE MYELOID LEUKAEMIA FEBRILE NEUTROPENIA 30
C ACUTE MYELOID LEUKAEMIA PYREXIA 30
C BONE MARROW CONDITIONING REGIMEN ACUTE GRAFT VERSUS HOST DISEASE 1
C BONE MARROW CONDITIONING REGIMEN BRONCHOPULMONARY ASPERGILLOSIS 3
C BONE MARROW CONDITIONING REGIMEN CHRONIC GRAFT VERSUS HOST DISEASE 1
C BONE MARROW CONDITIONING REGIMEN CYTOMEGALOVIRUS VIRAEMIA 1
C BONE MARROW CONDITIONING REGIMEN EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4
C BONE MARROW CONDITIONING REGIMEN FEBRILE NEUTROPENIA 1
C BONE MARROW CONDITIONING REGIMEN FUNGAL INFECTION 3
C BONE MARROW CONDITIONING REGIMEN HISTIOCYTOSIS HAEMATOPHAGIC 3
C BONE MARROW CONDITIONING REGIMEN MULTI-ORGAN FAILURE 3
C BONE MARROW CONDITIONING REGIMEN PYREXIA 1
C BONE MARROW FAILURE BRONCHOPULMONARY ASPERGILLOSIS 3
C BONE MARROW FAILURE EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3
C BONE MARROW FAILURE FUNGAL INFECTION 3
C BONE MARROW FAILURE HISTIOCYTOSIS HAEMATOPHAGIC 3
C BONE MARROW FAILURE MULTI-ORGAN FAILURE 3
C FEBRILE NEUTROPENIA ACUTE GRAFT VERSUS HOST DISEASE 1
C FEBRILE NEUTROPENIA CHRONIC GRAFT VERSUS HOST DISEASE 1
C FEBRILE NEUTROPENIA CYTOMEGALOVIRUS VIRAEMIA 1
C FEBRILE NEUTROPENIA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1
C FEBRILE NEUTROPENIA FEBRILE NEUTROPENIA 1
C FEBRILE NEUTROPENIA PYREXIA 1
C HIATUS HERNIA VISION BLURRED 1
C HYPERURICAEMIA DERMATITIS ALLERGIC 1
C MUSCLE SPASTICITY ASTHENIA 1
C MUSCLE SPASTICITY CATAPLEXY 2
C MUSCLE SPASTICITY CONDITION AGGRAVATED 1
C MUSCLE SPASTICITY DYSPHAGIA 1
C MUSCLE SPASTICITY FALL 2
C MUSCLE SPASTICITY LOSS OF CONSCIOUSNESS 2
C MUSCLE SPASTICITY MALAISE 2
C MUSCLE SPASTICITY MUSCULAR WEAKNESS 1
C MUSCLE SPASTICITY THERAPEUTIC RESPONSE DECREASED 1
C PLATELET COUNT DECREASED BRONCHOPULMONARY ASPERGILLOSIS 3
C PLATELET COUNT DECREASED EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3
C PLATELET COUNT DECREASED FUNGAL INFECTION 3
C PLATELET COUNT DECREASED HISTIOCYTOSIS HAEMATOPHAGIC 3
C PLATELET COUNT DECREASED MULTI-ORGAN FAILURE 3
C PREMEDICATION BRONCHOPULMONARY ASPERGILLOSIS 6
C PREMEDICATION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 6
C PREMEDICATION FUNGAL INFECTION 6
C PREMEDICATION HISTIOCYTOSIS HAEMATOPHAGIC 6
C PREMEDICATION MULTI-ORGAN FAILURE 6
C PRODUCT USED FOR UNKNOWN INDICATION BRONCHOPULMONARY ASPERGILLOSIS 87
C PRODUCT USED FOR UNKNOWN INDICATION CATAPLEXY 1
C PRODUCT USED FOR UNKNOWN INDICATION CONDITION AGGRAVATED 1
C PRODUCT USED FOR UNKNOWN INDICATION DYSPHAGIA 1
C PRODUCT USED FOR UNKNOWN INDICATION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 87
C PRODUCT USED FOR UNKNOWN INDICATION FALL 1
C PRODUCT USED FOR UNKNOWN INDICATION FUNGAL INFECTION 87
C PRODUCT USED FOR UNKNOWN INDICATION HISTIOCYTOSIS HAEMATOPHAGIC 87
C PRODUCT USED FOR UNKNOWN INDICATION LOSS OF CONSCIOUSNESS 1
C PRODUCT USED FOR UNKNOWN INDICATION MALAISE 1
C PRODUCT USED FOR UNKNOWN INDICATION MULTI-ORGAN FAILURE 87
C PRODUCT USED FOR UNKNOWN INDICATION MUSCULAR WEAKNESS 1
C PRODUCT USED FOR UNKNOWN INDICATION THERAPEUTIC RESPONSE DECREASED 1
C PROPHYLAXIS ACUTE GRAFT VERSUS HOST DISEASE 3
C PROPHYLAXIS BRONCHOPULMONARY ASPERGILLOSIS 24
C PROPHYLAXIS CHRONIC GRAFT VERSUS HOST DISEASE 3
C PROPHYLAXIS CYTOMEGALOVIRUS VIRAEMIA 3
C PROPHYLAXIS EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 27
C PROPHYLAXIS FEBRILE NEUTROPENIA 3
C PROPHYLAXIS FUNGAL INFECTION 24
C PROPHYLAXIS HISTIOCYTOSIS HAEMATOPHAGIC 24
C PROPHYLAXIS MULTI-ORGAN FAILURE 24
C PROPHYLAXIS PYREXIA 3
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION CYTOMEGALOVIRUS VIRAEMIA 7
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION EPSTEIN-BARR VIRAEMIA 7
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 7
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION HYPERBILIRUBINAEMIA 7
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION HYPERCHOLESTEROLAEMIA 7
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION HYPERTRIGLYCERIDAEMIA 7
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION PNEUMATOSIS INTESTINALIS 7
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION THROMBOTIC MICROANGIOPATHY 7
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION TREMOR 7
C RED BLOOD CELL COUNT DECREASED BRONCHOPULMONARY ASPERGILLOSIS 3
C RED BLOOD CELL COUNT DECREASED EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3
C RED BLOOD CELL COUNT DECREASED FUNGAL INFECTION 3
C RED BLOOD CELL COUNT DECREASED HISTIOCYTOSIS HAEMATOPHAGIC 3
C RED BLOOD CELL COUNT DECREASED MULTI-ORGAN FAILURE 3
Ads by Google